1-4 of 4
Paul Rennert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Initial results of a CRUK phase I/II, first in human trial of the CAR t-cell engager protein aleta-001 in patients who have received anti-CD19 CAR t-cell therapy for the treatment of b-cell malignancies

Free
Sridhar Chaganti, William Townsend, Bernard Maybury, Shankara Paneesha, Victoria Peacock, Alice Feast, Ram Malladi, Ben Uttenthal, Cathy Burton, Mary Owen, Adam Gibb, Jane Norman, Sunil Iyengar, Adrian Shields, Saly Al-Taei, Gareth Veal, Lucia Gargiulo, Jenny Craigen, Alka Lal, Emma Anderton, Aikaterini Lalatsa, Lisa Loram, Marco Schupp, Gary Acton, Paul Rennert
Journal: Blood
Blood (2025) 146 (Supplement 1): 925.
https://doi.org/10.1182/blood-2025-925
Published: 2025
Journal Articles

Characterization of Aleta-001, a CAR T Engager Designed to Optimize Responses and Prevent Relapses from CAR-19 Therapy

Free
Paul Rennert, Lihe Su, Lan Wu, Roy Lobb, Christine Ambrose
Journal: Blood
Blood (2021) 138 (Supplement 1): 1713.
https://doi.org/10.1182/blood-2021-153295
Published: 2021
Journal Articles

A Novel CD19-Anti-CD20 Bridging Protein Prevents and Reverses CD19-Negative Relapse from CAR19 T Cell Treatment In Vivo

Free
Paul Rennert, PhD, Lihe Su, PhD, Fay Dufort, PhD, Alyssa Birt, MS, Tom Sanford, Lan Wu, PhD, Christine Ambrose, PhD, Roy Lobb, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 252.
https://doi.org/10.1182/blood-2019-130654
Published: 2019
Journal Articles

CAR19 T Cells Redirected to Novel Antigens Mediate Robust Cytotoxicity Against Diverse Malignancies

Free
Paul Rennert, PhD, Christine Ambrose, PhD, Lihe Su, PhD, Fay Dufort, PhD, Lan Wu, PhD, Andreas Hombach, PhD, Hinrich Abken, PhD, Roy Lobb, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4457.
https://doi.org/10.1182/blood.V130.Suppl_1.4457.4457
Published: 2017